ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence

Cell Reports

Volumn 11, Issue 6, 2015, Pages 893-901

  Aird, Katherine M ^a   Worth, Andrew J ^b   Snyder, Nathaniel W ^b   Lee, Joyce V ^b   Sivanand, Sharanya ^b   Liu, Qin ^a   Blair, Ian A ^b   Wellen, Kathryn E ^b   Zhang, Rugang ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DEOXYRIBONUCLEOTIDE; DEOXYRIBONUCLEOTIDE TRIPHOSPHATE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMINE; MYC PROTEIN; PENTOSE PHOSPHATE; PROTEIN P53; UNCLASSIFIED DRUG; NUCLEOTIDE;

AMINO ACID METABOLISM; ARTICLE; CELL AGING; CELL METABOLISM; CELL STRESS; CONTROLLED STUDY; DNA REPLICATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; METABOLIC REGULATION; METABOLIC REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; REPLICATION STRESS; CELL LINE; DNA DAMAGE; ENZYME SPECIFICITY; GENE SILENCING; METABOLISM; NUCLEAR REPROGRAMMING; PENTOSE PHOSPHATE CYCLE; PHYSIOLOGICAL STRESS;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL AGING; CELL LINE; CELLULAR REPROGRAMMING; DNA DAMAGE; DNA REPLICATION; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTAMINE; HUMANS; NUCLEOTIDES; PENTOSE PHOSPHATE PATHWAY; PROTO-ONCOGENE PROTEINS C-MYC; STRESS, PHYSIOLOGICAL; SUBSTRATE SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929287721     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.04.014     Document Type: Article

References (37)

1. Aird K.M., Zhang G., Li H., Tu Z., Bitler B.G., Garipov A., Wu H., Wei Z., Wagner S.N., Herlyn M., Zhang R. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 2013, 3:1252-1265.
2. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
3. Bester A.C., Roniger M., Oren Y.S., Im M.M., Sarni D., Chaoat M., Bensimon A., Zamir G., Shewach D.S., Kerem B. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011, 145:435-446.
4. Blakley R.L., Vitols E. The control of nucleotide biosynthesis. Annu. Rev. Biochem. 1968, 37:201-224.
5. Burhans W.C., Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007, 35:7545-7556.
6. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
7. Cosentino C., Grieco D., Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 2011, 30:546-555.
8. Dang C.V., Le A., Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009, 15:6479-6483.
9. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre' M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
10. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin invivo. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
11. Finch R.A., Liu M.C., Cory A.H., Cory J.G., Sartorelli A.C. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv. Enzyme Regul. 1999, 39:3-12.
12. Finch R.A., Liu M., Grill S.P., Rose W.C., Loomis R., Vasquez K.M., Cheng Y., Sartorelli A.C. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem. Pharmacol. 2000, 59:983-991.
13. Groth P., Ausländer S., Majumder M.M., Schultz N., Johansson F., Petermann E., Helleday T. Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage. J.Mol. Biol. 2010, 402:70-82.
14. Jiang P., Du W., Wang X., Mancuso A., Gao X., Wu M., Yang X. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 2011, 13:310-316.
15. Kaplon J., Zheng L., Meissl K., Chaneton B., Selivanov V.A., Mackay G., van der Burg S.H., Verdegaal E.M., Cascante M., Shlomi T., et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013, 498:109-112.
16. Land H., Parada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983, 304:596-602.
17. Li H., Cai Q., Godwin A.K., Zhang R. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Mol. Cancer Res. 2010, 8:1610-1618.
18. Li M., Durbin K.R., Sweet S.M., Tipton J.D., Zheng Y., Kelleher N.L. Oncogene-induced cellular senescence elicits an anti-Warburg effect. Proteomics 2013, 13:2585-2596.
19. Maclean K.H., Kastan M.B., Cleveland J.L. Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. Mol. Cancer Res. 2007, 5:705-711.
20. Mannava S., Moparthy K.C., Wheeler L.J., Natarajan V., Zucker S.N., Fink E.E., Im M., Flanagan S., Burhans W.C., Zeitouni N.C., et al. Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage incells undergoing oncogene-induced senescence. Am. J. Pathol. 2013, 182:142-151.
21. Mazurek S., Zwerschke W., Jansen-Dürr P., Eigenbrodt E. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene 2001, 20:6891-6898.
22. Murray A.W. The biological significance of purine salvage. Annu. Rev. Biochem. 1971, 40:811-826.
23. Negrini S., Gorgoulis V.G., Halazonetis T.D. Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 2010, 11:220-228.
24. Nordlund P., Reichard P. Ribonucleotide reductases. Annu. Rev. Biochem. 2006, 75:681-706.
25. Patra K.C., Hay N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 2014, 39:347-354.
26. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annu. Rev. Biochem. 1988, 57:349-374.
27. Satyamoorthy K., DeJesus E., Linnenbach A.J., Kraj B., Kornreich D.L., Rendle S., Elder D.E., Herlyn M. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 1997, 7(2):S35-S42.
28. Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64:2627-2633.
29. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes invivo. Cell 1987, 49:465-475.
30. Tu Z., Aird K.M., Bitler B.G., Nicodemus J.P., Beeharry N., Xia B., Yen T.J., Zhang R. Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence. Dev. Cell 2011, 21:1077-1091.
31. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
32. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
33. Wilson P.M., Labonte M.J., Russell J., Louie S., Ghobrial A.A., Ladner R.D. A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphates. Nucleic Acids Res. 2011, 39:e112.
34. Yan M., Zhu C., Liu N., Jiang Y., Scofield V.L., Riggs P.K., Qiang W., Lynn W.S., Wong P.K. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state. Free Radic. Biol. Med. 2006, 41:640-648.
35. Yaswen P., Campisi J. Oncogene-induced senescence pathways weave an intricate tapestry. Cell 2007, 128:233-234.
36. Yuan J., Adamski R., Chen J. Focus on histone variant H2AX: to be or not to be. FEBS Lett. 2010, 584:3717-3724.
37. Zeman M.K., Cimprich K.A. Causes and consequences of replication stress. Nat. Cell Biol. 2014, 16:2-9.